Impax Pharmaceuticals Announces Extension of RYTARY FDA Review Date To January 9, 2015
September 17, 2014 at 09:01 AM EDT
Impax Pharmaceuticals, the branded products division of Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the U.S. Food and ...